文献速递外周动脉疾病

斑块旋切与血管内碎石术治疗股总动脉粥样硬化病变的疗效相当:系统评价与Meta分析

Atherectomy and Intravascular Lithotripsy Provide Comparable Outcomes for Common Femoral Artery Atherosclerotic Disease: A Systematic Review With Meta-analysis.
PubMed 文献 · J Endovasc Ther · 2025-05-23

该系统评价与Meta分析纳入16项研究(斑块旋切13项、960肢;血管内碎石术3项、66肢),比较两者治疗症状性股总动脉粥样硬化的结局。斑块旋切与血管内碎石术在技术成功(96% vs 97%)、 bailout支架置入比例(6% vs 8%)、免于靶病变血运重建(90% vs 91%)和保肢(97% vs 95%)方面均表现良好;血管内碎石术围手术期并发症有高于斑块旋切的趋势(16% vs 10%)。结论认为两者短期至中期结局相当,但需更长随访研究以制定临床推荐。

要点

  • 斑块旋切与血管内碎石术治疗股总动脉粥样硬化在技术成功、免于靶病变血运重建和保肢方面结局相当。
  • 血管内碎石术围手术期并发症有高于斑块旋切的趋势(16% vs 10%)。
  • 两者选择可由临床医生酌情决定,但需更长随访研究以形成临床推荐。

核心结论

  • 斑块旋切与血管内碎石术治疗症状性股总动脉粥样硬化在技术成功、免于靶病变血运重建和保肢方面短期至中期结局相当。
  • 这些发现提示两者之间的选择可由临床医生酌情决定,但需更长随访研究以制定临床推荐。

研究设计与样本

  • 系统评价与Meta分析,已在PROSPERO注册并遵循PRISMA指南。
  • 纳入标准为成年症状性股总动脉粥样硬化性狭窄或闭塞接受斑块旋切和/或血管内碎石术治疗。
  • 共纳入16项研究:斑块旋切13项(960肢),血管内碎石术3项(66肢)。
  • 由2名评价者独立提取数据,汇总5个选定结局,采用MMAT评估偏倚风险。

主要发现

  • 技术成功:斑块旋切96% vs 血管内碎石术97%。
  • bailout支架置入比例:斑块旋切6% vs 血管内碎石术8%。
  • 免于靶病变血运重建:斑块旋切90% vs 血管内碎石术91%。
  • 保肢:斑块旋切97% vs 血管内碎石术95%。
  • 围手术期并发症:血管内碎石术有高于斑块旋切的趋势(16% vs 10%)。

关键数值与推荐

  • 5项斑块旋切研究和2项血管内碎石术研究满足全部7项MMAT标准。
  • 4项斑块旋切研究满足6项MMAT标准。
  • 4项斑块旋切研究和1项血管内碎石术研究满足4或5项MMAT标准。

临床怎么用

  • 该系统评价与Meta分析可帮助临床医生在股总动脉粥样硬化的血管内治疗之间做出循证选择。
  • 斑块旋切与血管内碎石术在技术成功、保肢和免于靶病变血运重建方面短期至中期结局相当。
  • 两者之间的选择可由临床医生酌情决定,但需更长随访研究以形成临床推荐。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To identify, synthesize, and critically appraise the published studies reporting outcomes of atherectomy and/or intravascular lithotripsy (IVL) for symptomatic common femoral artery (CFA) atherosclerosis and therefore provide support in clinical decision-making. DESIGN: Systematic review with meta-analysis. DATA SOURCES AND REVIEW METHODS: This review was registered in PROSPERO and followed the Preferred Reporting Items for Systematic Reviews and Meta-analysis guidelines. A search was performed on MEDLINE and Embase. Inclusion criteria were prospective or retrospective comparative or non-comparative studies and research letters, published between Jan 01, 2000 and Dec 01, 2023, written in English or French, that reported on adults with symptomatic atherosclerotic stenosis or occlusion, localized within the CFA, treated with atherectomy and/or IVL. Study and lesion characteristics, clinical and technical outcomes were extracted independently by 2 reviewers, and data were pooled for 5 selected outcomes. Risk of bias was assessed with Mixed Methods Appraisal Tool (MMAT). RESULTS: Sixteen studies (13 on atherectomy, 960 limbs; 3 on IVL, 66 limbs) were included. Both atherectomy and IVL had good outcomes in terms of technical success (96% vs 97%), proportion of bailout stenting (6% vs 8%), freedom from target lesion revascularization (TLR; 90% vs 91%), and limb salvage (97% vs 95%). IVL tended to have more perioperative complications than atherectomy (16% vs 10%). Five studies on atherectomy and 2 studies on IVL met all 7 MMAT criteria, 4 studies on atherectomy met 6 criteria, while 4 studies on atherectomy and 1 study on IVL met 4 or 5 criteria. CONCLUSION: Atherectomy and IVL can have equally good short- to mid-term outcomes for the treatment of symptomatic CFA atherosclerosis in terms of technical success, as well as freedom from TLR and limb salvage. Although these findings suggest that the choice between atherectomy and IVL for CFA atherosclerosis can be at the discretion of the clinician, further studies with longer follow-up are needed to formulate clinical recommendations.Clinical ImpactThis systematic review with meta-analysis can help clinicians to make evidence-based choices between endovascular treatments for common femoral artery (CFA) atherosclerosis. It shows that atherectomy and intravascular lithotripsy (IVL) have equally good short- to mid-term outcomes in treating CFA atherosclerosis, both in terms of technical success, as well as limb salvage and freedom from target lesion revascularization. These findings suggest that the choice between atherectomy and IVL for CFA atherosclerosis can be at the discretion of the clinician, however, further studies with longer follow-up are needed to formulate clinical recommendations.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Bouchareine N, Daniel G, Ramos-Pascual S, et al. Atherectomy and Intravascular Lithotripsy Provide Comparable Outcomes for Common Femoral Artery Atherosclerotic Disease: A Systematic Review With Meta-analysis. J Endovasc Ther. 2025. PMID: 40407115. doi:10.1177/15266028251335174

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。